#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3012	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2941	243.7	0	.	n	.	0	C207T	SNP	207	207	C	833	833	T	295	T,C,G	117,145,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3012	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2941	243.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1810	1810	C	344	C,G,A	317,2,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4986	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4145	290.4	0	.	n	.	0	T695C	SNP	695	695	T	1347	1347	C	311	C,G	283,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4986	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4145	290.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2623	2623	C	366	C,T	345,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4986	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4145	290.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2697	2697	A	359	A	332	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4986	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4145	290.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3249	3249	C	312	C	293	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4986	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4145	290.4	0	HET	.	.	.	A1638G,T	.	1638	1638	A	2290	2290	A	388	A,G,T	285,82,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	330	folP	855	855	100.0	folP.l6.c4.ctg.1	1949	39.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1245	1247	AGC	49;49;49	A;G;C	47;47;47	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	984	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4042	58.9	1	SNP	p	S91F	1	.	.	271	273	TTC	992	994	TTC	61;61;61	T;T;C	54;56;56	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	984	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4042	58.9	1	SNP	p	D95G	1	.	.	283	285	GGC	1004	1006	GGC	63;65;65	G;G;C	57;58;58	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	984	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4042	58.9	1	SNP	p	G95N	0	.	.	283	285	GGC	1004	1006	GGC	63;65;65	G;G;C	57;58;58	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	984	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4042	58.9	0	HET	.	.	.	C2320G	.	2320	2320	C	3041	3041	C	73	C,G	56,10	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	346	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	2042	41.3	1	SNP	p	G45D	0	.	.	133	135	GGC	794	796	GGC	71;71;71	G;G;C	65;65;66	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	234	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1715	33.0	0	.	n	.	0	A197.	DEL	197	197	A	916	916	A	97	A	89	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3401	70.0	1	SNP	p	D86N	0	.	.	256	258	GAC	817	819	GAC	59;59;60	G;A;C	43;30;42	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3401	70.0	1	SNP	p	S87R	1	.	.	259	261	CGT	820	822	CGT	60;60;62	C;G;T	50;36;49	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3401	70.0	1	SNP	p	R87I	0	.	.	259	261	CGT	820	822	CGT	60;60;62	C;G;T	50;36;49	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3401	70.0	1	SNP	p	R87W	0	.	.	259	261	CGT	820	822	CGT	60;60;62	C;G;T	50;36;49	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3401	70.0	1	SNP	p	S88P	0	.	.	262	264	TCC	823	825	TCC	62;61;61	T;C,T;C	54;53,2;57	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	842	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3539	57.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1993	1995	GGC	60;62;63	G;G;C	51;50;50	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2612	60.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1401	1403	GCC	81;81;81	G;C;C	75;75;75	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2612	60.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1404	1406	ATG	81;83;83	A;T,A;G	75;76,1;77	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2612	60.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1416	1418	ACC	88;88;86	A;C,A;C	81;81,1;80	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2612	60.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1416	1418	ACC	88;88;86	A;C,A;C	81;81,1;80	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2612	60.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1917	1919	ACC	69;69;65	A;C,A;C	60;58,1;59	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2612	60.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1971	1973	GCG	61;61;61	G;C;G	54;47;51	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2612	60.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1971	1973	GCG	61;61;61	G;C;G	54;47;51	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2612	60.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2094	2096	GGT	44;43;43	G;G,T;T,C	42;38,3;40,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2612	60.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2103	2105	AGC	39;40;40	A,G;G;C,G	25,1;32;28,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2612	60.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2121	2123	CCG	39;38;38	C,G;C;G	33,1;30;29	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	970	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3967	59.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2089	2091	CCG	89;89;89	C,G,T;C,G,T;G,C	74,4,3;73,2,2;54,8	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	386	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2557	36.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	900	900	C	22	C	18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	442	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2362	45.6	0	.	p	.	0	I45V	NONSYN	133	135	ATT	696	698	GTT	64;63;63	G;T,G;T	61;57,1;60	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	442	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2362	45.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1191	1193	AGA	52;52;52	A;G,T;A	51;50,1;51	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	442	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2362	45.6	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1317	1319	GAA	70;72;73	G,T;A,T;A	65,1;66,1;68	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	442	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2362	45.6	1	SNP	p	G120K	1	.	.	358	360	AAG	921	923	AAG	63;63;61	A,C;A;G,A	59,2;62;56,3	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	442	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2362	45.6	1	SNP	p	N121D	0	.	.	361	363	AAC	924	926	AAC	61;61;61	A;A;C,A	57;60;57,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	442	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2362	45.6	1	SNP	p	A121N	1	.	.	361	363	AAC	924	926	AAC	61;61;61	A;A;C,A	57;60;57,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1628	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5431	72.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	220	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1925	27.8	1	SNP	p	V57M	1	.	.	169	171	ATG	1015	1017	ATG	60;60;62	A;T;G,C	56;56;57,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
